CORETECH 5 (MLCOT.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:MLCOT - FR0013371507 - Common Stock
MLCOT.PA Key Statistics, Chart & Performance
The current stock price of MLCOT.PA is 0.15 EUR. In the past year, price increased by 1328.57%.
MLCOT.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.36 | 210.27B | ||
| SAN.PA | SANOFI | 11.28 | 208.91B | ||
| SNW.DE | SANOFI | 11.28 | 208.31B | ||
| MRK.DE | MERCK KGAA | 13.6 | 50.43B | ||
| UCB.BR | UCB SA | 37.46 | 46.78B | ||
| UNC.DE | UCB SA | 37.17 | 46.41B | ||
| 1BAYN.MI | BAYER AG-REG | 5.75 | 30.17B | ||
| BAYN.DE | BAYER AG-REG | 5.71 | 29.95B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.84 | 10.64B | ||
| IPN.PA | IPSEN | 12.1 | 10.42B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 100.96 | 9.35B | ||
| 1JAZZ.MI | JAZZ PHARMACEUTICALS PLC | 18.46 | 7.88B |
Related stock screener links
About MLCOT.PA
Company Profile
Reboost Blockchain Corp. is a pharmaceutical company, whiche engages in the research, development, and commercialization of medicines and food supplements for animals. The company is headquartered in Paris, Ile-De-France. The firm specializes in the development and commercialization of veterinary solutions for the management of the main pathologies of companion animals. The company differentiates its concept of service for the customers in two levels: the follow-up of the animals by veterinarians trained in the use of cannabidiol (CBD) on the dosage, the indications, the evaluation of the effectiveness of the products and concern on the plant with a Hemp professional. Its employees are specialized in the veterinary and phytology fields, trained in the use of the products. The company has contact with more than 50 product suppliers in Europe, Canada, and the United States.
Company Info
CORETECH 5
5 Rue De Castiglione
Paris ILE-DE-FRANCE FR
Employees: 0
Phone: 33142461173
CORETECH 5 / MLCOT.PA FAQ
What does CORETECH 5 do?
Reboost Blockchain Corp. is a pharmaceutical company, whiche engages in the research, development, and commercialization of medicines and food supplements for animals. The company is headquartered in Paris, Ile-De-France. The firm specializes in the development and commercialization of veterinary solutions for the management of the main pathologies of companion animals. The company differentiates its concept of service for the customers in two levels: the follow-up of the animals by veterinarians trained in the use of cannabidiol (CBD) on the dosage, the indications, the evaluation of the effectiveness of the products and concern on the plant with a Hemp professional. Its employees are specialized in the veterinary and phytology fields, trained in the use of the products. The company has contact with more than 50 product suppliers in Europe, Canada, and the United States.
Can you provide the latest stock price for CORETECH 5?
The current stock price of MLCOT.PA is 0.15 EUR. The price increased by 14.5% in the last trading session.
Does MLCOT stock pay dividends?
MLCOT.PA does not pay a dividend.
What is the ChartMill rating of CORETECH 5 stock?
MLCOT.PA has a ChartMill Technical rating of 5 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
What sector and industry does CORETECH 5 belong to?
CORETECH 5 (MLCOT.PA) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the market cap for CORETECH 5?
CORETECH 5 (MLCOT.PA) has a market capitalization of 2.52M EUR. This makes MLCOT.PA a Nano Cap stock.
What is the ownership structure of CORETECH 5 (MLCOT.PA)?
You can find the ownership structure of CORETECH 5 (MLCOT.PA) on the Ownership tab.
MLCOT.PA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to MLCOT.PA. When comparing the yearly performance of all stocks, MLCOT.PA is one of the better performing stocks in the market, outperforming 99.66% of all stocks.
MLCOT.PA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |